Tuesday, 3 September 2019

Promising Bioconjugate Vaccine Against Hypervirulent Superbug Klebsiella

A promising bioconjugate Vaccine against superbug Klebsiella
Researchers have now produced and tested a promising bioconjugate
vaccine against Klebsiella in mice. This is a vaccine that protects
against this worrisome superbug i.e, a hypervirulent form of the
bacteria Klebsiella pneumoniae. Researchers, Washington University
School of Medicine in St. Louis and VaxNewMo, a St. Louis-based
startup., […]

The post Promising Bioconjugate Vaccine Against Hypervirulent Superbug
Klebsiella appeared first on BioTecNika .

https://www.biotecnika.org/2019/09/promising-bioconjugate-vaccine-against-hypervirulent-superbug-klebsiella/

Uncategorized

No comments:

Post a Comment